Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹61 Cr₹101 Cr₹135 Cr₹143 Cr₹118 Cr

What is the latest Total Non-Current Liabilities ratio of NATCO PHARMA ?

The latest Total Non-Current Liabilities ratio of NATCO PHARMA is ₹61 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹61 Cr
Mar2023₹101 Cr
Mar2022₹135 Cr
Mar2021₹143 Cr
Mar2020₹118 Cr

How is Total Non-Current Liabilities of NATCO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹61 Cr
-39.30
Mar2023 ₹101 Cr
-25.61
Mar2022 ₹135 Cr
-5.46
Mar2021 ₹143 Cr
21.31
Mar2020 ₹118 Cr -

Compare Total Non-Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,494.5 Cr -1.2% 4.1% -16.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,919.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -4.3% -8% -4.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.2%

4.1%

-16.8%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses